Profil
Sarah Mathieson, formerly the Chief Executive Officer of The Research Autism Information Service, Vice President-Corporate Communications at Adamas Pharmaceuticals LLC, Global Head-Communications & Engagement at GSK Plc, and Head-Communications at Pfizer Ltd., also served as the Senior Vice President-Corporate Affairs at Eiger BioPharmaceuticals, Inc. from 2022 to 2023.
Anciens postes connus de Sarah Mathieson
| Sociétés | Poste | Fin |
|---|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2023 |
| ADAMAS PHARMACEUTICALS, INC. | Public Communications Contact | 24/11/2021 |
Pfizer Ltd.
 Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Public Communications Contact | - |
| GSK PLC | Public Communications Contact | - |
The Research Autism Information Service
 The Research Autism Information Service Miscellaneous Commercial ServicesCommercial Services The Research Autism Information Service engages in the provision of autism information services. The company was founded in 2004 and is headquartered in London, the United Kingdom. | Chief Executive Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GSK PLC | Health Technology |
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
Pfizer Ltd.
Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Health Technology |
The Research Autism Information Service
The Research Autism Information Service Miscellaneous Commercial ServicesCommercial Services The Research Autism Information Service engages in the provision of autism information services. The company was founded in 2004 and is headquartered in London, the United Kingdom. | Commercial Services |
